CpG preconditioning reduces accumulation of lysophosphatidylcholine in ischemic brain tissue after middle cerebral artery occlusion
Journal Article
·
· Analytical and Bioanalytical Chemistry
- Uppsala Univ. (Sweden). Dept. of Chemistry; OSTI
- Oregon Health & Science Univ., Portland, OR (United States). Dept. of Molecular Microbiology & Immunology
- Uppsala Univ. (Sweden). Dept. of Chemistry
- Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Physical Sciences Division; Purdue Univ., West Lafayette, IN (United States). Dept. of Chemistry
Ischemic stroke is one of the major causes of death and permanent disability in the world. However, the molecular mechanisms surrounding tissue damage are complex and further studies are needed to gain insights necessary for development of treatment. Prophylactic treatment by administration of cytosine-guanine (CpG) oligodeoxynucleotides has been shown to provide neuroprotection against anticipated ischemic injury. CpG binds to Toll-like receptor 9 (TLR9) causing initialization of an inflammatory response that limits visible ischemic damages upon subsequent stroke. Here, we use nanospray desorption electrospray ionization (nano-DESI) mass spectrometry imaging (MSI) to characterize molecular effects of CpG preconditioning prior to middle cerebral artery occlusion (MCAO) and reperfusion. By doping the nano-DESI solvent with appropriate internal standards, we can study and compare distributions of phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) in the ischemic hemisphere of the brain despite the large changes in alkali metal abundances. Our results show that CpG preconditioning not only reduces the infarct size but it also decreases the degradation of PC and accumulation of LPC species, which indicates reduced cell membrane breakdown and overall ischemic damage. Our findings show that molecular mechanisms of PC degradation are intact despite CpG preconditioning but that these are limited due to the initialized inflammatory response.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
- Grant/Contract Number:
- AC05-76RL01830
- OSTI ID:
- 1815711
- Journal Information:
- Analytical and Bioanalytical Chemistry, Journal Name: Analytical and Bioanalytical Chemistry Journal Issue: 10 Vol. 413; ISSN 1618-2642
- Publisher:
- SpringerCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury
Matrix Effects in Biological Mass Spectrometry Imaging: Identification and Compensation
Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis
Journal Article
·
Sat Jan 31 23:00:00 EST 2015
· Journal of Cerebral Blood Flow and Metabolism
·
OSTI ID:1710221
Matrix Effects in Biological Mass Spectrometry Imaging: Identification and Compensation
Journal Article
·
Mon Jul 21 00:00:00 EDT 2014
· Analyst, 139(14):3528-3532
·
OSTI ID:1134515
Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis
Journal Article
·
Sun Jan 14 23:00:00 EST 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23127538